Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 32,520	$ 15,611	$ 55,924	$ 29,818
Adjustments to reconcile net income to net cash flows from operating activities:
Provision for credit losses on accounts receivable	100	100	357	616
Reserve for product returns			2,022	2,498
Provision for credit losses on notes receivable			3,996	0
Inventory write-down			0	1,181	$ 1,400
Amortization on patents and tooling			417	637
Amortization and depreciation	7,080	7,860	14,417	15,533
Amortization of debt issuance costs			1,811	1,570
Amortization of operating leases			5,953	5,621
Deferred income taxes			(24,992)	(36,870)
Change in fair value of contingent liability			44	27
Stock-based compensation			22,481	24,617
Loss from investment in unconsolidated entity			23	0
Changes in operating assets and liabilities (net of business acquisitions):
Accounts receivable			4,668	(583)
Inventory			16,484	(523)
Other current and non-current assets			601	432
Accounts payable, accrued expenses and other current liabilities			(30,437)	(4,696)
Deferred revenue			3,022	3,105
Operating lease liabilities			(6,751)	(6,796)
Other liabilities			2,776	(2,920)
Cash flows from operating activities			72,816	33,267
Cash flows used in investing activities:
Business acquisition, net of cash acquired			0	(9,696)
Additions to property and equipment			(5,058)	(3,393)
Issuances of notes receivable			(500)	(300)
Receipt of payments on notes receivable			26	28
Capitalized software development costs			(632)	(115)
Purchase of investment in unconsolidated entities			(2,950)	(200)
Purchases of other intangible assets			(45)	(5,915)
Cash flows used in investing activities			(9,159)	(19,591)
Cash flows from / (used in) financing activities:
Proceeds from issuance of convertible senior notes			500,000	0
Payments of debt issuance costs			(13,946)	0
Purchases of capped calls related to convertible senior notes			(63,050)	0
Payments of deferred consideration for acquisitions			(4,569)	(1,655)
Purchases of treasury stock, including transaction costs			(75,000)	(6,726)
Payments of tax withholdings related to vesting of restricted stock units	(3,400)	0	(3,401)	0
Purchases of redeemable noncontrolling interest			0	(832)
Payments of acquired debt			0	(389)
Issuances of common stock from equity-based plans			6,734	1,513
Cash flows from / (used in) financing activities			346,768	(8,089)
Effect of exchange rate changes on cash, cash equivalents and restricted cash			(133)	(124)
Net increase in cash, cash equivalents and restricted cash			410,292	5,463
Cash, cash equivalents and restricted cash at beginning of the period			701,079	622,879	622,879
Cash, cash equivalents and restricted cash at end of the period	1,111,371	628,342	1,111,371	628,342	701,079
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	1,104,539	627,041	1,104,539	627,041	696,983
Restricted cash included in other current assets and other assets	6,832	1,301	6,832	1,301
Total cash, cash equivalents and restricted cash	$ 1,111,371	$ 628,342	$ 1,111,371	$ 628,342	$ 701,079